EUVIMEDEUVIMED entdecken
Crossref

Propofol Sedation with a Target-Controlled Infusion Pump and Bispectral Index Monitoring System in Older Patients Undergoing Antegrade Balloon-Assisted Enteroscopy

Natsumi Maeda, Akira Higashimori, Hiroshi Okamura, Koji Fujimoto, Yumie Kobayashi, Akinobu Nakata, Rieko Nakata, Yu Nishida, Hirotsugu Maruyama, Yuji Nadatani, Masaki Ominami, Shusei Fukunaga und 4 weitere

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-025-09427-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Natsumi Maeda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan. Hauptthemen laut MEDLINE: Propofol, Hypnotics and Sedatives, Consciousness Monitors, Endoscopy, Gastrointestinal. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adequate sedation is essential for balloon-assisted enteroscopy (BAE). While propofol sedation using target-controlled infusion (TCI) and bispectral index (BIS) monitoring is considered effective, its safety in older patients undergoing antegrade BAE remains unclear. This study evaluated the safety and efficacy of TCI/BIS-guided propofol sedation in older patients. METHODS: In this retrospective study, 369 patients who underwent antegrade BAE under propofol sedation between April 2017 and March 2024 were categorized into three age groups: younger (< 50 years, N = 123), middle-aged (50-69 years, N = 121), and older (≥ 70 years, N = 125). Propofol dosage, sedation-related adverse events, and procedural outcomes were compared. Multivariate analysis was compared to identify risk factors for major sedation-related events, including hypoxemia, hypotension, bradycardia. RESULTS: Older patients required significantly lower target concentrations and total doses of propofol than younger and middle-aged patients (younger: 2.0 µg/mL, middle-aged: 1.6 µg/mL, older: 1.4 µg/mL, P < 0.01; younger: 414 mg, middle-aged: 312 mg, older: 212 mg, P < 0.01). Induction time was significantly longer in younger patients (P < 0.01). Major sedation-related adverse event rates did not significantly differ by age group. Multivariate analysis showed no association between age and adverse events. Low preoperative systolic blood pressure increased the risk of hypotension (OR = 2.32), chronic respiratory disease increased the risk of hypoxemia (OR = 2.97), and ASA class III increased the risk of bradycardia (OR = 3.38). All procedures were completed successfully without severe adverse events. CONCLUSION: TCI/BIS-guided propofol sedation may be acceptable for older patients undergoing antegrade BAE, who require a lower propofol dose than younger patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolHypnotics and SedativesConsciousness MonitorsEndoscopy, GastrointestinalProcedural SedationHumansAgedMaleMiddle AgedFemaleRetrospective StudiesAge FactorsInfusion PumpsAged, 80 and overAnesthetics, IntravenousAdult

Stichwörter der Autor:innen

Balloon-assisted enteroscopyBispectral index monitoringOlder patientsPropofol sedationTarget-controlled infusion

Substanzen

PropofolHypnotics and SedativesAnesthetics, Intravenous

Autor:innen und Institutionen

  • Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan. higamo@omu.ac.jp.
  • Department of Internal Medicine, Naniwaikuno Hospital, Osaka, Japan. higamo@omu.ac.jp.
  • Department of Laboratory Medicine and Medical Informatics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Premier Preventive Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Zitieren

APA

Maeda, N., Higashimori, A., Okamura, H., Fujimoto, K., Kobayashi, Y., Nakata, A., Nakata, R., Nishida, Y., Maruyama, H., Nadatani, Y., Ominami, M., Fukunaga, S., Otani, K., Hosomi, S., Tanaka, F., & Fujiwara, Y. (2025). Propofol Sedation with a Target-Controlled Infusion Pump and Bispectral Index Monitoring System in Older Patients Undergoing Antegrade Balloon-Assisted Enteroscopy. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09427-8

Vancouver

Maeda N, Higashimori A, Okamura H, Fujimoto K, Kobayashi Y, Nakata A, et al. Propofol Sedation with a Target-Controlled Infusion Pump and Bispectral Index Monitoring System in Older Patients Undergoing Antegrade Balloon-Assisted Enteroscopy. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-025-09427-8

BibTeX
@article{Maeda2025,
  author = {Maeda, Natsumi and Higashimori, Akira and Okamura, Hiroshi and Fujimoto, Koji and Kobayashi, Yumie and Nakata, Akinobu and Nakata, Rieko and Nishida, Yu and Maruyama, Hirotsugu and Nadatani, Yuji and Ominami, Masaki and Fukunaga, Shusei and Otani, Koji and Hosomi, Shuhei and Tanaka, Fumio and Fujiwara, Yasuhiro},
  title = {Propofol Sedation with a Target-Controlled Infusion Pump and Bispectral Index Monitoring System in Older Patients Undergoing Antegrade Balloon-Assisted Enteroscopy},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-025-09427-8}
}
Kostenlos starten →